S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin

American Journal of Pathology

Volumn 157, Issue 6, 2000, Pages 2101-2109

  Sakagashira, Setsuya ^a   Hiddinga, Henry J ^a   Tateishi, Kayoko ^b   Sanke, Tokio ^c   Hanabusa, Tadashi ^c   Nanjo, Kishio ^c   Eberhardt, Norman L ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c WAKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; FLUORESCENCE ACTIVATED CELL SORTER; GENE MUTATION; GENETIC TRANSFECTION; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0033638450     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64848-1     Document Type: Article

References (36)

1. Seminars in: Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance
2. Genetics of non-insulin-dependent (type-II) diabetes mellitus
3. Maturity-onset diabetes of the young (MODY): A new challenge for pediatric diabetologists
4. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients
5. An islet amyloid peptide is derived from an 89-amino acid proteolytic processing
6. Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits
7. Islet amyloid polypeptide: Actions and role in the pathogenesis of diabetes
8. Islet amyloid polypeptide: A review of its biology and potential roles in the pathogenesis of diabetes mellitus
9. Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation
10. Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis
11. Intracellular amyloidogenesis by human islet amyloid polypeptide induces apoptosis in COS-1 cells
12. Electroporation in 'intracellular' buffer increases cell survival
13. A novel assay to measure loss of plasma membrane asymmetry during apoptosis of adherent cells in culture
14. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes
15. Small heat shock proteins inhibit in vitro A-beta(1-42) amyloidogenesis
16. Transient gene expression control: Effects of transfected DNA stability and trans-activation by viral early proteins
17. Tripartite management of unfolded proteins in the endoplasmic reticulum
18. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1
19. Fluorometric examination of tissue amyloid fibrils in murine senile amyloidosis: Use of the fluorescent indicator, thioflavine T
20. Kinetic analysis of amyloid fibril polymerization in vitro
21. A novel in vitro assay of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation
22. Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins
23. Neurotoxicity of human amylin in rat primary hippocampal cultures: Similarity to Alzheimer's disease amyloid-beta neurotoxicity
24. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
25. Amyloid deposition as the central event in the aetiology of Alzheimer's disease
26. A new pathogenic mutation in the APP gene (1716V) increases the relative proportion of A beta 42(43)
27. Production of amyloid beta protein from normal amyloid beta-protein precursor (beta APP) and the mutated beta APPS linked to familial Alzheimer's disease
28. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
29. Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide
30. The S20G islet-associated polypeptide gene mutation in familial NIDDM
31. Glucose tolerance in Japanese subjects with S20G mutation of the amylin gene
32. Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients
33. Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus
34. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)
35. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)
36. Mutations in the hepatocyte nuclear factor-1alpha/MODY3 gene in Japanese subjects with early- and late-onset NIDDM